Bing

McKesson (NYSE:MCK) was downgraded by Zacks from a “buy” rating to a “hold” rating in a report issued on Wednesday, Marketbeat.com reports. According to Zacks, “McKesson’s first quarter results were strong with the company easily …
Ticker Report · 1 day ago
[Business Wire] – McKesson Corporation today announced that James Beer, executive vice president and chief financial officer, will present at the 2015 Morgan Stanley Global Healthcare Conference in New York at 11 …
Jutia Group · 8/26/2015
McKesson Corporation
McKesson (NYSE:MCK) was upgraded by Zacks from a “hold” rating to a “buy” rating in a research report issued on Wednesday, Marketbeat reports. The brokerage presently has a $211.00 price target on the …
wkrb13.com · 8/29/2015
More from Bing News
Traders sold shares of McKesson (NYSE:MCK) on strength during trading on Friday after Raymond James lowered their price target on the stock from $265.00 to $245.00, Market Beat Ratings reports. $83.80 million flowed into the stock on the tick-up and …
sleekmoney.com · 8/28/2015
McKesson (NYSE:MCK) has received an average recommendation of “Buy” from the fourteen ratings firms that are currently covering the firm, Marketbeat.com reports. Fourteen analysts have rated the stock with a …
Mideast Times · 8/20/2015
Amag Pharmaceuticals (AMAG): AMAG stock is up 2.5% today. Some of the biggest losers among healthcare stocks include: Mckesson Corp (MCK): MCK stock is down 4.7% today on 4 times normal volume. Abbvie Inc. Common Stock (ABBV): ABBV …
Investor Place · 8/25/2015
Healthcare Stocks
A quick look at McKesson's stock performance over the past few years appears anything but boring. Although shares are down somewhat with the recent overall market pullback, McKesson is still up 228% over the past five years. MCK data by YCharts …
NASDAQ · 8/28/2015
The stock should run into initial resistance at its 200-day moving average (MA) of $222.29 and subsequent resistance at its 50-day MA of $225.74. McKesson share prices have moved between a 52-week high of $243.61 and the current low of $160.10 and …
Financial News Network Online · ByAdrienne Chilton · 8/24/2015
Group President Paul C Julian sold 55,666 shares of MCK stock on 07/15/2015 at the average price of $233.45. McKesson delivers pharmaceuticals, medical supplies and healthcare information technology. The company has a market cap of $54.24 billion ...
Guru Focus · 7/21/2015
NEW YORK (TheStreet) -- Shares of McKesson Corp. (MCK - Get Report) are up 3.32% to $180.01 on heavy ... largely solid financial position with reasonable debt levels by most measures, solid stock price performance and notable return on equity.
The Street · 5/13/2014

McKesson Corporation

American Company
McKesson Corporation is an American company distributing pharmaceuticals at a retailsale level and providing health information technology, m…
McKesson Corporation is an American company distributing pharmaceuticals at a retailsale level and providing health information technology, medical supplies, and care management tools. The company had sales of $122 billion in 2012.
Data from: Wikipedia · Freebase